STS launches their fourth mobile application developed for the FDA

STS designed and developed the Drugs@FDA Express mobile application for the U.S. Food and Drug Administration. On this mobile app, the public can search for information about FDA-approved brand and generic prescription and over-the-counter human drugs and biological therapeutic products. The FDA currently operates the Drugs@FDA webpage, which includes information about drug products approved by the agency, including patient information, drug labeling, approval letters, reviews and other information. The Drugs@FDA Express mobile app is a streamlined version of Drugs@FDA, allowing users to search on their mobile devices for certain product information based on product name, active ingredient or application number using a single search box. Some information (like labeling supplements and approval letters) won’t be available on the app, but can be found on the Drugs@FDA webpage.

The app will also feature the most recent product approvals, within seven days, links to the Drugs@FDA glossary and frequently asked questions. It will also provide contact information for the FDA’s Division of Drug Information, druginfo@fda.hhs.gov.

This free mobile app can be downloaded via iTunes (for Apple devices) and the Google Play store (for Android devices).